{"id":19396,"date":"2021-11-05T11:29:27","date_gmt":"2021-11-05T10:29:27","guid":{"rendered":"https:\/\/idibell.cat\/?p=19396"},"modified":"2023-08-01T18:31:46","modified_gmt":"2023-08-01T16:31:46","slug":"descrits-nous-factors-predictors-de-mortalitat-en-lembolia-pulmonar-greu","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2021\/11\/descrits-nous-factors-predictors-de-mortalitat-en-lembolia-pulmonar-greu\/","title":{"rendered":"Descrits nous factors predictors de mortalitat en l\u2019emb\u00f2lia pulmonar greu"},"content":{"rendered":"<p>Un estudi portat a terme per investigadors de l\u2019IDIBELL i l\u2019Hospital Universitari de Bellvitge han descrit nous predictors de mortalitat en el tractament endovascular de l\u2019emb\u00f2lia pulmonar greu. Els resultats del seu treball acaben de ser publicats a la revista\u00a0<a href=\"https:\/\/www.mdpi.com\/2077-0383\/10\/20\/4716\"><em>Journal of Clinical Medicine<\/em><\/a>.<\/p>\n<p>La malaltia tromboemb\u00f2lica \u00e9s la tercera causa de mortalitat\u00a0cardiovascular, despr\u00e9s de la cardiopatia isqu\u00e8mica i de l\u2019ictus. La seva forma de presentaci\u00f3 m\u00e9s greu \u00e9s l\u2019emb\u00f2lia pulmonar, que es produeix quan material tromb\u00f2tic provinent d\u2019una trombosi venosa profunda es despla\u00e7a pel sistema ven\u00f3s fins a la circulaci\u00f3 arterial pulmonar.<\/p>\n<p>Tot i que la majoria d\u2019aquests casos poden ser abordats amb un tractament farmacol\u00f2gic anticoagulant o fibrinol\u00edtic, els casos\u00a0m\u00e9s greus que, pel seu risc de sagnat, no poden rebre aquests tractaments s\u00f3n tractats mitjan\u00e7ant t\u00e8cniques de reperfusi\u00f3 endovascular, realitzades a unitats d\u2019Angioradiologia d\u2019hospitals terciaris. L\u2019Hospital Universitari de Bellvitge \u00e9s centre de refer\u00e8ncia en aquestes t\u00e8cniques per a m\u00e9s de dos milions d\u2019habitants de l\u2019\u00e0rea del sud de Catalunya.<\/p>\n<p>Es tracta d\u2019un estudi retrospectiu realitzat en 63 pacients amb emb\u00f2lia pulmonar greu que han rebut aquest tipus de tractament a l\u2019Hospital Universitari de Bellvitge entre el gener de 2010 i el desembre de 2020, amb l\u2019objectiu d\u2019identificar factors predictors de mortalitat.<\/p>\n<p>Els resultats han identificat com a predictors de mortalitat el fet de tenir m\u00e9s de 70 anys, i el fet que pr\u00e8viament el pacient hagi estat sotm\u00e8s a una fibrin\u00f2lisi sist\u00e8mica. Aix\u00ed mateix, ha determinat que els pacients als quals s\u2019havia implantat un filtre de vena cava inferior durant el procediment de reperfusi\u00f3 endovascular presenten menys mortalitat a curt i llarg termini.<\/p>\n<p>Aquests resultats proporcionen un millor coneixement que contribu\u00efr\u00e0 a la presa de decisions cl\u00edniques en els casos m\u00e9s complexos d\u2019emb\u00f2lia pulmonar.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em>L\u2019Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l&#8217;Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l&#8217;Institut Catal\u00e0 de la Salut, l&#8217;Institut Catal\u00e0 d&#8217;Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n<p><em>L\u2019IDIBELL \u00e9s membre del Campus d&#8217;Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L&#8217;any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un estudi portat a terme per investigadors de l\u2019IDIBELL i l\u2019Hospital Universitari de Bellvitge han descrit nous predictors de mortalitat en el tractament endovascular de l\u2019emb\u00f2lia pulmonar greu.<\/p>\n","protected":false},"author":8,"featured_media":19397,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[470,416,334,340,466,457,467],"tags":[],"class_list":["post-19396","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tribio","category-malalties-neurologiques-i-neurogenetica","category-medicina-translacional","category-neurociencies","category-p-de-malalties-cardiovasculars-respiratories-sistemiques-i-denvelliment-cellular","category-p-de-neurociencies","category-pneumologia"],"publishpress_future_action":{"enabled":false,"date":"2024-12-25 10:09:01","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/19396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=19396"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/19396\/revisions"}],"predecessor-version":[{"id":19399,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/19396\/revisions\/19399"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/19397"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=19396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=19396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=19396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}